TD Cowen analyst Joseph Thome raised the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $125.00 (from $117.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE